Your browser doesn't support javascript.
loading
Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard dose.
Breccia, Massimo; Cannella, Laura; Stefanizzi, Caterina; Latagliata, Roberto; Nanni, Mauro; Diverio, Daniela; Santopietro, Michelina; Federico, Vincenzo; Alimena, Giuliana.
Affiliation
  • Breccia M; Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome, Italy. breccia@bce.uniroma1.it
Hematol Oncol ; 28(2): 89-92, 2010 Jun.
Article in En | MEDLINE | ID: mdl-19728398
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myeloid, Chronic-Phase / Biomarkers, Tumor / Fusion Proteins, bcr-abl / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2010 Type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myeloid, Chronic-Phase / Biomarkers, Tumor / Fusion Proteins, bcr-abl / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2010 Type: Article Affiliation country: Italy